Ontology highlight
ABSTRACT: Background
Cerebrovascular events, dementia, and cancer can contribute to physical disability with activities of daily living (ADL). It is unclear whether low-dose aspirin reduces this burden in aging populations. In a secondary analysis, we now examine aspirin's effects on incident and persistent ADL disability within a primary prevention aspirin trial in community-dwelling older adults.Methods
The ASPREE (ASPirin in Reducing Events in the Elderly) trial of daily 100 mg aspirin versus placebo recruited 19 114 healthy adults aged 70+ years (65+ years if U.S. minority) in Australia and the United States. Six basic ADLs were assessed every 6 months. Incident ADL disability was defined as inability or severe difficulty with ≥1 ADL; persistence was confirmed if the same ADL disability remained after 6 months. Proportional hazards modeling compared time to incident or persistent ADL disability for aspirin versus placebo; death without prior disability was a competing risk.Results
Over a median of 4.7 years, incident ADL disability was similar in those receiving aspirin (776/9525) and placebo (787/9589) with walking, bathing, dressing, and transferring the most commonly reported. Only 24% of incident ADL disability progressed to persistent. Persistent ADL disability was lower in the aspirin group (4.3 vs 5.3 events/1000 py; hazard ratio [HR] = 0.81, 95% confidence interval [CI]: 0.66-1.00), with bathing and dressing the most common ADL disabilities in both groups. Following persistent ADL disability, there were more deaths in the aspirin group (24 vs 12).Discussion
Low-dose aspirin in initially healthy older people did not reduce the risk of incident ADL disability, although there was evidence of reduced persistent ADL disability.
SUBMITTER: Woods RL
PROVIDER: S-EPMC8514067 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
Woods Robyn L RL Espinoza Sara S Thao Le T P LTP Ernst Michael E ME Ryan Joanne J Wolfe Rory R Shah Raj C RC Ward Stephanie A SA Storey Elsdon E Nelson Mark R MR Reid Christopher M CM Lockery Jessica E JE Orchard Suzanne G SG Trevaks Ruth E RE Fitzgerald Sharyn M SM Stocks Nigel P NP Williamson Jeff D JD McNeil John J JJ Murray Anne M AM Newman Anne B AB
The journals of gerontology. Series A, Biological sciences and medical sciences 20211001 11
<h4>Background</h4>Cerebrovascular events, dementia, and cancer can contribute to physical disability with activities of daily living (ADL). It is unclear whether low-dose aspirin reduces this burden in aging populations. In a secondary analysis, we now examine aspirin's effects on incident and persistent ADL disability within a primary prevention aspirin trial in community-dwelling older adults.<h4>Methods</h4>The ASPREE (ASPirin in Reducing Events in the Elderly) trial of daily 100 mg aspirin ...[more]